RxDoctor Payments Data

James Lee, MD

Otolaryngology/Facial Plastic Surgery · Westwood, NJNPI 1457335564

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 26.1% of the total.

$4,186in general payments, 2019–2025

Across 187 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Sanofi$785
  • Regeneron Healthcare Solutions, Inc.$698
  • Optinose US, Inc.$484
  • GSK$258
  • Stryker$247
  • plus $620 from 15 others

What the payments were for

  • Food & beverage$4,186100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,186 in reported general payments places this provider in the 80th percentile of 36 otolaryngology/facial plastic surgery providers in New Jersey.

See all otolaryngology/facial plastic surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$415,147
Medicare patients
1,459
Services billed
3,648

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab13$48,589
Azelastine Hcl517$11,240
Fluticasone Propionate569$9,659
Ipratropium Bromide233$5,598
Mometasone Furoate229$3,490
Ofloxacin60$2,619
Triamcinolone Acetonide53$1,707
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort28$1,403
Fluocinolone Acetonide Oil19$853
Dexamethasone38$820
Clotrimazole37$746
CefuroximeCefuroxime Axetil44$653
Mupirocin55$484
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav45$385
Montelukast Sodium57$369

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Westwood

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →